QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) All Versions of this Article: jpet.104.065078v1 310/1/301    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kam, A. Y. F. Articles by Wong, Y. H. Search for Related Content PubMed PubMed Citation Articles by Kam, A. Y. F. Articles by Wong, Y. H.

CELLULAR AND MOLECULAR

-Opioid Receptor Signals through Src and Focal Adhesion Kinase to Stimulate c-Jun N-Terminal Kinases in Transfected COS-7 Cells and Human Monocytic THP-1 Cells

Department of Biochemistry, Molecular Neuroscience Center, and Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China

Received January 1, 2004; accepted March 1, 2004.

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
Opioid peptides exert diverse physiological functions through their cognate receptors. One subtype of the opioid receptors, -opioid receptor, is endogenously expressed in human monocytic THP-1 cells. Stimulation of the THP-1 cells with a -opioid receptor-selective agonist exerted a G_i-dependent activation of c-Jun N-terminal kinase (JNK). To further investigate the signaling mechanism by which the -opioid receptor regulates JNK activity, heterologous expression assays in COS-7 cells were utilized. Overexpression of G_t in COS-7 cells clearly suppressed -opioid receptor-stimulated JNK activity, indicating that the pathway is primarily regulated by G. In both THP-1 and transfected COS-7 cells, pretreatment of the selective Src family kinase inhibitor pyrazolopyrimidine PP1 abolished the JNK activation, whereas the epidermal growth factor receptor inhibitor AG1478 [N-(3-chlorophenyl)-6,7-dimethoxy-4-quinazolinanine] failed to do that. Furthermore, the JNK activation in response to -opioid receptor was suppressed by an autophosphorylation-resistant mutant of focal adhesion kinase (FAK). Consistently, activated -opioid receptor induced Src stimulation and FAK autophosphorylation and promoted the formation of Src-FAK complex. The participation of small GTPases as well as a guanine nucleotide exchange factor was also implicated because dominant-negative mutants of Rac, Cdc42, and Son-of-sevenless (Sos) attenuated the agonist-induced activation of JNK. These studies demonstrate that the activation of JNK by -opioid receptors is routed via G, Src, FAK, Sos, Rac, and Cdc42.

Although opioid-mediated immunomodulations are well described, the underlying signal transduction mechanisms required for these activities remain elusive. It is well known that -opioid receptors can stimulate mitogen-activated protein kinases (MAPKs). Indeed, MAPKs are one of the most versatile signaling kinases that modulate numerous biological responses ranging from neuronal differentiation to immune responses. In the regulation of extracellular signal-regulated protein kinases (ERKs), the -opioid receptor appears to utilize a G- and Ras-dependent mechanism in both C6 glioma cells (Bohn et al., 2000) and transfected COS-7 cells (Belcheva et al., 1998). With regard to the regulation of immune responses, the c-Jun N-terminal kinase (JNK), another member of the MAPK family, can be potently activated by inflammatory cytokines such as tumor necrosis factor- and IL-1, bacterial endotoxins, and environmental stress. JNK is responsible for phosphorylating various transcription factors including c-Jun, JunB, Elk-1, activating transcription factor 2, and nuclear factor of activated T cells (NF-AT) (reviewed in Davis, 2000). Behrens et al. (2001) reported that c-Jun stimulation by JNK was essential for thymocyte apoptosis, whereas JNK-enhanced-NF-AT activity is involved in T cell proliferation. Similar to -opioids, a role of JNK in IL-2 production is complicated and controversial. In mixed lymphocyte populations of JNK1 or two knockout mice, a clear suppression on the level of IL-2 has been revealed (Sabapathy et al., 2001), supporting the importance of JNK in modulating IL-2 expression. However, an opposite observation has emerged wherein CD4⁺ T cells completely lacking JNK have elevated IL-2 levels (Dong et al., 2000). Recently, morphine and [D-Ala²,N-MePhe⁴,Gly-ol⁵]-enkephalin (DAMGO, a synthetic µ-opioid) have been shown to induce the apoptosis of macrophage and T lymphocytes through p38 MAPK and JNK, respectively (Singhal et al., 2001, 2002). Activation of JNK by µ- and -opioid receptors have been reported (Kam et al., 2003, 2004), raising the possibility that -opioid receptors may modulate immune functions via JNK.

Ample evidence indicates that G protein-coupled receptors (GPCRs) can transactivate the epidermal growth factor (EGF) receptor (Daub et al., 1996), as well as activate nonreceptor tyrosine kinases such as the focal adhesion kinase (FAK; Schlaepfer et al., 1999) and Src family kinases (Luttrell et al., 1996). These tyrosine kinases are implicated in the transmission of signals to the MAPK cascades. Indeed, constitutive activation of JNK has been demonstrated in Rat-2 fibroblasts expressing v-Src oncoprotein and in human embryonic kidney 293T cells expressing membrane-bound forms of FAK (Li and Smithgall, 1998; Igishi et al., 1999). Moreover, small GTPases of the Ras and Rho families appear to form an integral part of the signaling route linking GPCRs to MAPK. Members of the Rho family (Rac and Cdc42) act as upstream activators of the JNK pathway (reviewed in Davis, 2000). The activities of the small GTPases are in turn regulated by guanine nucleotide exchange factors (GEFs). Thus, a multitude of signaling molecules may relay the activation signal from GPCRs to JNK. In the present study, we explored the ability of -opioid receptors to stimulate JNK in human monocytic THP-1 cells and transfected COS-7 cells. Upon stimulation of -opioid receptors, increases in Src and FAK autophosphorylations were detected. Our study also revealed that the -opioid receptor required Rac and Cdc42, as well as a GEF, Son-of-sevenless (Sos), to stimulate JNK.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Materials. The cDNA of mouse -opioid receptor (in the pCMV6 vector) was kindly provided by Dr. G. Bell (University of Chicago, Chicago, IL). JNK-HA cDNA was provided by Dr. T. A. Voyno-Yasenetskaya (University of Illinois, Chicago, IL). The plasmids encoding Src and its dominant-negative mutant (SrcK295R/527F) as well as dominant-negative Ras (RasS17N), Rac (RacT17N), Cdc42 (Cdc42T17N), and RhoA (RhoAT19N) were obtained as previously described (Kam et al., 2003). The cDNAs encoding the p21-binding domain (PBD) from human PAK1 and Sos-Pro were kind donations from Dr. G. M. Bokoch (Scripps Research Institute, La Jolla, CA) and Dr. R. J. Lefkowitz (Duke University Medical Center, Durham, North Carolina), respectively. The HA-tagged cDNAs of FAK site-directed mutants, including FAKY397F, FAKY925F, and FAKK454R, were kindly donated by Dr. T. Hunter (Salk Institute for Biological Studies, La Jolla, CA). [-³²P]ATP was purchased from PerkinElmer Life and Analytical Sciences (Boston, MA). Anti-phospho-JNK, anti-JNK, and anti-phospho-Src-Y416 antibodies were obtained from Cell Signaling Technology Inc. (Beverly, MA). Antiserum against G_t was obtained from Transduction Laboratories (Lexington, KY). Anti-phospho-FAK (Y397), anti-FAK, and anti-Rac antibodies were purchased from Upstate Biotechnology (Lake Placid, NY), and rabbit polyclonal antibody against human Cdc42 was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Pertussis toxin (PTX) and 12CA5 (anti-HA) antibody were purchased from List Biological Laboratories Inc. (Campbell, CA) and Roche Applied Science (Indianapolis, IN), respectively. Tyrphostin AG1478 and pyrazolopyrimidine PP1 were purchased from Calbiochem-Novabiochem Co. (La Jolla, CA). Cell culture reagents, including LipofectAMINE PLUS, were obtained from Invitrogen (Carlsbad, CA). (±)-trans-U-50,488 methanesulfonate (U-50,488H), nor-binaltorphimine dihydrochloride (nor-BNI,) and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).

Cell Culture and Transfection. COS-7 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50 µg/ml streptomycin in a humidified atmosphere containing 5% CO₂ at 37°C. One day before the transfection, cells were seeded onto 6-well plates at a density of 3 x 10⁵ cells/well. Transfection was performed by means of LipofectAMINE PLUS reagents according to the supplier's instructions, and the transfected cells were kept in the growth medium for 36 h. Under the same physical conditions, human monocytic THP-1 cells were cultured in RPMI 1640 medium supplemented with 50 µM 2-mercaptoethanol, 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50 µg/ml streptomycin.

In Vitro JNK Assay. Transfected COS-7 cells were serumstarved for 18 h in the presence or absence of PTX (100 ng/ml) before drug treatment. Where appropriate, additional treatments of PP1 (25 µM, 30 min) and AG1478 (500 nM, 30 min) were applied to the starved cells. Cells were then treated with the assay medium (Dulbecco's modified Eagle's medium with 20 mM HEPES) in the absence or presence of 100 nM U-50,488H for 15 min at 37°C and lysed in 500 µl of lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM EDTA, 40 mM NaP₂O₇, 1% Triton X-100, 1 mM dithiothreitol, 200 µMNa₃VO₄, 100 µM phenylmethylsulfonyl fluoride, 2 µg/ml leupeptin, 4 µg/ml aprotinin, and 0.7 µg/ml pepstatin) and shaken on ice for 30 min. The lysates were centrifuged at 14,000g for 5 min at 4°C. Fifty microliters of each sample were used for the detection of JNK-HA expression, and 450 µl were incubated for 1 h at 4°C with anti-HA antibody (2 µg/sample), followed by incubation with 30 µlof protein A-agarose (50% slurry) at 4°C for 1 h. The resulting immunoprecipitates were washed twice with lysis buffer and twice with kinase assay buffer (40 mM HEPES, pH 8.0, 5 mM Mg(C₂H₃O₂)₂, 1 mM EGTA, 1 mM dithiothreitol, 200 µM Na₃VO₄). Washed immunoprecipitates were resuspended in 40 µl of kinase assay buffer containing 5 µg of glutathione S-transferase (GST)-c-Jun per reaction, and the kinase reactions were initiated by the addition of 10 µl of ATP buffer (50 µM ATP with 2 µCi of [-³²P]ATP per sample). After a 30-min incubation at 30°C with occasional shaking, the reactions were terminated by adding 10 µl of 6x Laemmli sample buffer and boiled for 5 min, and the samples were subjected to 12% SDS-polyacrylamide gel electrophoresis (PAGE). The radioactivity incorporated into GST-c-Jun was detected by autoradiography, and the signal intensity was quantified using a PhosphorImager SI 445 (Amersham Biosciences, Sunnyvale, CA).

Western Blot. THP-1 cells were plated at 1 x 10⁶ cells/ml in serum-free media and maintained for 18 to 24 h with or without PTX (100 ng/ml). If necessary, THP-1 cells were preincubated with different inhibitors before the addition of U-50,488H. Cells were then lysed in 200 µl of lysis buffer. Supernatants of cell lysates were collected by centrifugation at 14,000g for 5 min, mixed with 40 µl of 6x sample buffer, and boiled for 5 min. Proteins of each sample (150 µg) were resolved by 12% SDS-PAGE, and then transferred to nitrocellulose membranes. Phosphorylated and total kinases (JNK, Src, and FAK) were detected by specific antibodies, followed with horseradish peroxidase-conjugated secondary antibody. Immunoblots were developed in the presence of enhanced chemiluminescence reagents, and the images detected in X-ray films were quantified by densitometric scanning using the Eagle Eye II still video system (Stratagene, La Jolla, CA).

Immunoprecipitation. Quiescent THP-1 cells (1 x 10⁶ cells/ml) were treated with 100 nM U-50,488H at different durations (Fig. 5C). The stimulation was terminated by adding cold lysis buffer (500 µl). The cell lysates were cleared by centrifugation at 14,000g for 5 min at 4°C and then were incubated with 2 µg of monoclonal anti-Src antibodies for 3 h at 4°C, followed by incubation with 30 µl of protein A-agarose (4°C for 1 h). Immunoprecipitates were washed three times with lysis buffer and collected by centrifugation. Proteins were boiled in 40 µl of 2x sample buffer, resolved on a 12% SDS-PAGE, and transferred to nitrocellulose membranes. The membranes were analyzed by Western blotting using anti-FAK antibody.

View larger version (34K): [in this window] [in a new window]   Fig. 5. The effects of FAK mutants on U-50,488H-induced JNK activation. A, COS-7 cells were cotransfected with the cDNAs of -opioid receptor and JNK-HA, together with vector, FAKY397F, FAKK454R, or FAKY925F (0.5 µg for each). The transfected cells were exposed to 100 nM U-50,488H for 15 min. Total cell lysates (50 µl) were subjected to immunoblotting with the anti-HA antibody. Results are the mean ± S.E. from five independent experiments. *, U-50,488H significantly stimulated JNK activity (Bonferroni corrected t test, P < 0.05). B, THP-1 cells were incubated with 100 nM U-50,488H for different times and then lysed (upper panel). In addition, COS-7 cells were transfected with plasmids encoding either vector, G1, G2, G12, Gi2 wild type (WT), or constitutively activated Gi2 (QL; bottom panel). Both cell lysates were subjected to immunoblotting with antisera against phospho-FAK (Tyr397) or FAK. Results are representative of two or three separate experiments. C, THP-1 cells were treated as described in B, but the lysates were immunoprecipitated (IP) with the anti-c-Src antibody and then subjected to Western blotting (WB) with anti-FAK antibody. The membranes were stripped and reprobed with anti-c-Src antibody. Results are representative of two separate experiments.

GTPase Pull-Down Assay. GTPase pull-down assay was performed as described previously (Kam et al., 2003). The cDNAs of PAK-PBD in pGEX-4T3 were expressed in Escherichia coli as a fusion protein with GST. The fusion proteins were purified from glutathione-Sepharose beads. Serum-starved THP-1 cells were lysed with 500 µl of Mg²⁺-containing lysis buffer (MLB; 25 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.25% sodium deoxycholate, 10% glycerol, 25 mM NaF, 10 mM MgCl₂, 1 mM EDTA, 1 mM sodium orthovanadate, 10 µg/ml leupeptin, 10 µg/ml aprotinin). Cell lysates were centrifuged at 4°C for 10 min at 14,000g. The supernatant (50 µl) was used for detecting total Rac and Cdc42. Cell lysates (450 µl) were incubated with 10 µg of GST-PAK-PBD and 15 µl of 50% slurry of glutathione-Sepharose beads at 4°C for 60 min with constant rotation. Bound proteins were collected by centrifugation, and pellets were washed three times in Mg²⁺-containing lysis buffer and finally suspended in 2x sample buffer (40 µl). Proteins were resolved by 12% SDS-PAGE, and the bound Rac or Cdc42 were analyzed by immunoblotting using antiserum against Rac or Cdc42, respectively.

	Results

Top Abstract Materials and Methods Results Discussion References

 
Stimulation of JNK by -Opioid Receptor in Human Monocytic THP-1 Cells. We began our study by examining the ability of an endogenous -opioid receptor to stimulate JNK in human monocytic THP-1 cells. The activation of JNK was monitored by immunoblotting using an antiserum, which recognizes the p46/p54 JNK isoforms dually phosphorylated at threonine 183 and tyrosine 185. Incubation of THP-1 cells with the -opioid receptor-selective agonist, U-50,488H (100 nM), increased JNK phosphorylation in a time-dependent manner, with a peak at around 5 to 15 min. The JNK activity gradually declined to the basal level in the next 30 to 45 min of the agonist incubation (Fig. 1A). The dose-response relationship of U-50,488H on the JNK phosphorylation in THP-1 cells was also investigated. As shown in Fig. 1, a significant JNK stimulation was detected with as low as 10 nM U-50,488H, and the maximum was attained by around 0.1 to 1 µM. To further map the signaling pathway by which the -opioid receptor induced JNK stimulation, heterologous expression assays in COS-7 cells were employed as described previously (Kam et al., 2003). Suppression of intracellular signaling components can be conveniently achieved by cotransfecting their dominant-negative mutants, without affecting the expression of receptors (unpublished observations). Plasmids expressing the -opioid receptor and HA-tagged JNK (HA-JNK) were cotransfected into COS-7 cells, and the JNK activity was measured by an in vitro kinase assay using GST-c-Jun as a substrate. In comparison with time course studies in THP-1 cells, the kinetics of JNK activation in transfected COS-7 cells was slower and reached a maximum after 15 min of incubation of U-50,488H (Fig. 1B). Although the dose-response curve in COS-7 cells was similar to that of THP-1 cells, at least 100 nM U-50,488H was required to elicit a significant JNK activation in the transfected cells (Fig. 1B). This small discrepancy between the transfected cells and native cells might be due to their fundamental difference in compartmentalization of receptors and G proteins (Shapira et al., 2000). In all subsequent experiments, THP-1 cells and COS-7 cells were exposed to 100 nM U-50,488H for 5 and 15 min, respectively.

View larger version (34K): [in this window] [in a new window]   Fig. 1. -Opioid receptors induced JNK activation in a time- and dose-dependent manner. A, THP-1 cells were incubated in serum-free growth medium for 18 to 24 h before application of 100 nM U-50,488H (U-50) for the indicated periods (left panel) or before stimulation with increasing concentrations of U-50,488H for 5 min (right panel). Phosphorylated and total JNK were detected by different specific antibodies and quantified by densitometry. Data are presented as fold increase in phosphorylated p46 and p54 JNK over nonstimulated cells (basal, B) and represent the mean ± S.E. from four independent experiments. B, COS-7 cells were transiently cotransfected with the cDNAs of JNK-HA (0.5 µg) and -opioid receptor (0.5 µg). Transfected cells were serum-starved for 18 to 24 h and subsequently incubated with 100 nM U-50,488H at different times (left panel) or stimulated with different doses for 15 min (right panel). The in vitro JNK assay was performed as described under Materials and Methods. A representative autoradiogram shows the phosphorylated GST-c-Jun, and an immunoblot shows the expression of JNK-HA in the cell lyates. Results are shown as fold increase in JNK-HA activity over nonstimulated cells (basal, B) and are the mean ± S.E. from five separate experiments. *, U-50,488H significantly induced JNK activation (Bonferroni corrected t test, P < 0.05).

-Opioid Receptor-Induced JNK Activation Is Mainly Mediated by G Derived from G_i/G_o Protein. Opioid receptors are prototypical G_i/G_o-coupled receptors, because their cellular signals can be effectively blocked by PTX. For example, opioid-induced activation of ERK1/2 in transfected COS-7 cells is mediated via PTX-sensitive G proteins (Belcheva et al., 1998). Yet, it has been found that opioid receptors can additionally utilize numerous PTX-insensitive G proteins, such as G_z and G₁₆, to regulate downstream effectors (Lai et al., 1995; Lee et al., 1998). Since G₁₆ is implicated in JNK stimulation and its expression is restricted in hematopoietic cells, we asked whether the -opioid receptor stimulated JNK via PTX-sensitive or PTX-insensitive G proteins in THP-1 cells. THP-1 cells were incubated with 100 ng/ml PTX for 18 h prior to stimulation with U-50,488H. As illustrated in Fig. 2A, the JNK activation in the -opioid-stimulated THP-1 cells was completely abrogated by pretreatment with PTX. Likewise, a complete blockade of the JNK stimulation by PTX was also observed in COS-7 cells (Fig. 2A). These results thus suggested a preferential coupling between the -opioid receptor and G_i/G_o protein to regulate JNK in both cell lines. Additionally, the JNK activation in U-50,488H-treated THP-1 cells was reversed by cotreatment with the -opioid receptor-selective antagonist nor-BNI (10 µM; data not shown), indicating a specific involvement of -opioid receptor-mediated response.

View larger version (38K): [in this window] [in a new window]   Fig. 2. Attenuation of JNK activation by -opioid receptor in the presence of PTX or G-scavenging protein. A, THP-1 cells and transfected COS-7 cells (as in legend to Fig. 1B) were serum-starved in the absence or presence of 100 ng/ml PTX for 18 h before stimulation with 100 nM U-50,488H for 5 min (left panel) and 15 min (right panel), respectively. B, COS-7 cells were cotransfected with cDNAs encoding JNK-HA and -opioid receptor, together with vector or Gt (0.5 µg for each). The JNK activity was determined at 15 min in the absence or presence of 100 nM U-50,488H. Values shown represent the mean ± S.E. from four or five separate experiments. *, U-50,488H significantly stimulated JNK activity (Bonferroni corrected t test, P < 0.05).

It is generally believed that G dimers act as potent activators of JNK (Coso et al., 1996). The contribution of G dimers in linking the -opioid receptor to the JNK pathway was evaluated using the subunit of transducin (G_t), which functions as a G scavenger protein. As shown in Fig. 2B, overexpression of G_t in COS-7 cells markedly attenuated the JNK stimulation by U-50,488H, whereas it did not affect the total amount of HA-JNK. Hence, the -opioid receptor regulates the JNK pathway mainly through a G-dependent mechanism.

-Opioid Receptor-Initiated JNK Activation Requires Src Family Tyrosine Kinases but Not EGF Receptor Transactivation. The capability of the v-Src oncoprotein to stimulate JNK has been demonstrated in Rat-2 fibroblasts (Li and Smithgall, 1998). Our recent study has also found that overexpression of wild-type Src kinase is sufficient to stimulate the JNK activity in COS-7 cells (Kam et al., 2003). Additionally, Src kinase can in turn be activated upon overexpression of G or by stimulation of lysophosphatidic acid (LPA) (Luttrell et al., 1996), suggesting that the kinase probably participates in a number of GPCR-regulated signaling pathways. We therefore investigated the role of Src family tyrosine kinases in the activation of JNK by -opioid receptors. In THP-1 cells, U-50,488H not only stimulated the JNK activity, but also led to the phosphorylation of c-Src kinase at residue Y416, as detected in an anti-phospho-Tyr416 c-Src immunoblot (Fig. 3A, top panel). Furthermore, the U-50,488H-increased JNK and Src activities were abolished by pretreatment with a potent inhibitor of Src family tyrosine kinases PP1 (10 µM, 30 min; Fig. 3A, bottom panel). These results thus indicate that Src family tyrosine kinases are capable of linking the -opioid receptor to JNK pathway.

View larger version (29K): [in this window] [in a new window]   Fig. 3. PP1 and a dominant-negative mutant of Src kinases block -opioid-induced JNK activation. A, THP-1 cells were preincubated with or without PP1 (10 µM, 30 min) prior to the addition with U-50,488H (100 nM, 5 min). The cell lysates were subjected to immunoblotting with antisera against phospho-c-Src (Tyr416) or c-Src (upper panel) and phospho-JNK or total JNK (bottom panel). B, the -opioid receptor and JNK-HA were expressed together in COS-7 cells with or without PP1 pretreatment (10 µM, 30 min; left panel) or in the absence or presence of dominant-negative Src kinase (SrcDN; 0.5 µg for each; right panel). Then the JNK activity was stimulated with 100 nM U-50,488H for 15 min. Results are the mean ± S.E. from five or six separate experiments. *, U-50,488H significantly induced JNK activation (Bonferroni corrected t test, P < 0.05).

In agreement with the results obtained in Fig. 3A, pretreatment of transfected COS-7 cells with PP1 attenuated the JNK activation in response to the application of U-50,488H (Fig. 3B). To investigate the specific contribution of Src kinase in the pathway, cDNA encoding a kinase-deficient mutant of Src was cotransfected into COS-7 cells together with the -opioid receptor and HA-JNK. Figure 3B depicts the inhibitory effect of kinase-inactive Src overexpression on the JNK activation by U-50,488H, thus confirming the importance of Src kinase in the pathway. Additional studies are necessary to identify whether other members of the Src family are also involved in the JNK regulation by -opioid receptor.

Many studies support the idea that GPCRs such as those for endothelin-1, LPA, and -thrombin are able to activate the ERK pathway by transactivating EGF receptors (Daub et al., 1996). Similarly, the µ-opioid receptor-induced ERK activation requires a Src-dependent transactivation of EGF receptor (Belcheva et al., 2001). Therefore, we asked whether EGF receptor transactivation is required for JNK activation by the -opioid receptor. In control experiments, 100 ng/ml EGF treatment of THP-1 cells clearly increased JNK activity, which was suppressed in the presence of AG1478 (an inhibitor for EGF receptor; 500 nM, 30 min; Fig. 4A). The inhibitory effect of AG1478 on EGF-induced JNK activation was also observed in COS-7 cells expressing HA-JNK (data not shown). These studies confirmed that there were functional EGF receptors in both THP-1 cells and COS-7 cells, and the inhibitory effect of AG1478 on the EGF receptor was verified. As shown in Fig. 4, pretreatment of THP-1 cells and transfected COS-7 cells with AG1478 had no effect on the JNK activation following stimulation by U-50,488H. The EGF receptor is apparently not involved in the signaling route linking the -opioid receptor to JNK.

View larger version (27K): [in this window] [in a new window]   Fig. 4. No influence of EGF receptor inhibition on -opioid receptor-mediated JNK activity. A, THP-1 cells were preincubated with or without AG1478 (500 nM, 30 min) and were then exposed to 100 ng/ml EGF (right) or 100 nM U-50,488H (left) for 5 min. B, COS-7 cells overexpressing -opioid receptor and JNK-HA were pretreated with AG1478 (500 nM, 30 min) before application of U-50,488H (100 nM, 15 min). Values shown represent the mean ± S.E. from five independent experiments. *, U-50,488H significantly stimulated JNK activity (Bonferroni corrected t test, P < 0.05).

A Src-Binding Site Mutant of FAK Blocks the JNK Stimulation by the -Opioid Receptor. Similar to Src tyrosine kinases, ample evidence supports a role for integrin-linked FAK in mediating mitogenic responses induced by GPCR, including those for vasopressin, endothelin, and bombesin (reviewed in Schlaepfer et al., 1999). As membrane-bound forms of FAK have been shown to exhibit a remarkable increase in JNK activity (Igishi et al., 1999), we were prompted to examine whether FAK participates in the -opioid receptor-initiated JNK pathway. Several site-directed mutants of FAK, including FAKY397F, FAKY925F, and FAKK454R (Schlaepfer and Hunter, 1997), were employed. Y397 is a major site for FAK autophosphorylation and binds the SH2 domain of Src family kinases after stimulation. The bound Src subsequently phosphorylates FAK on Y925, which creates a binding site for a Grb2 SH2 domain. Once a FAK-Grb2 complex is formed, downstream signaling pathways will be initiated (reviewed in Schlaepfer et al., 1999). Moreover, the K454 residue is essential for the kinase activity of FAK (reviewed in Schlaepfer et al., 1999). Figure 5A revealed the effects of FAK site-directed mutants on the JNK activation following stimulation of COS-7 cells with U-50,488H. Compared with the JNK stimulation in vector control, only overexpression of the Src-binding site mutant FAKY397F in COS-7 cells blocked the JNK activation (Fig. 5A). Despite coexpression of kinase-inactive FAKK454R, the ability of U-50,488H to induce JNK activation was unaffected (Fig. 5A). We also found no effect of Grb2-binding site mutant FAKY925F on the JNK activity (Fig. 5A). As determined by immunodetection with anti-HA antibody, coexpression of FAK-interfering mutants did not affect the total amount of JNK. Next, we investigated whether the activated -opioid receptor would lead to the autophosphorylation of FAK. After THP-1 cells were challenged with U-50,488H, a time-dependent FAK phosphorylation at Tyr397 was observed and reached a maximum at 3 to 15 min (Fig. 5B, left panel). To assess the relative contribution of G and G_i in the receptor signaling to FAK autophosphorylation, COS-7 cells were transfected with vector, G₁, G₂, G₁₂, and wild type of G_i2 or its constitutively activated mutant. As shown by the anti-phospho FAK Tyr397 immunoblot in Fig. 5B (right panel), overexpression of G₁₂ was able to increase FAK autophosphorylation, but the activated mutant of G_i2 was ineffective, suggesting that the -opioid receptor promoted FAK autophosphorylation through a G-dependent pathway. Since activated FAK is known to associate with Src, we further attempted to detect the FAK-Src complex in response to the -opioid receptor by coimmunoprecipitation. Stimulation of THP-1 cells with U-50,488H not only contributed to FAK phosphorylation at Tyr397, but it also triggered a transient formation of FAK-Src complex (peaking at 3 min; Fig. 5C). These experiments confirmed that the -opioid receptor required Tyr397 autophosphorylation on FAK and probably the subsequent association with Src kinase to stimulate JNK activity.

Small GTPases and a GEF Are Necessary for -Opioid-Stimulated JNK Activity. Small GTPases of the Ras and Rho families are believed to represent an integral part of the signaling route linking many cell surface receptors to MAPK. In GPCR-mediated JNK pathways, members of the Rho family, Rac and Cdc42, have been proposed as upstream regulators of MAPK kinase kinase in the JNK cascade but operate downstream of nonreceptor tyrosine kinases. Yamauchi et al. (2002) have recently reported that endothelin induces JNK stimulation by a sequential mechanism through Src kinases and Rho family GTPases Rac1 and Cdc42. To clarify which GTPases participate in the signaling cascade connecting the -opioid receptor to JNK, dominant-negative mutants of small GTPases including RasS17N, RacT17N, Cdc42T17N, and RhoT19N were cotransfected together with the receptor and HA-JNK into COS-7 cells. The dominant-negative mutants have a high affinity for GDP and compete with endogenous GTPases for coupling to their specific GEFs. Overexpression of RacT17N and Cdc42T17N resulted in the abolition of JNK activity evoked by -opioid receptors. In contrast, RasS17N and RhoT19N did not affect the JNK activation (Fig. 6A). To confirm the role of Rac and Cdc42 in the signaling pathway, we measured the GTP-bound form of endogenous Rac and Cdc42 following stimulation of THP-1 cells with U-50,488H by using the GST-PAK-PBD pull-down assay (Kam et al., 2003). As illustrated in Fig. 6B, stimulation of the -opioid receptor by U-50,488H led to a transient activation of Rac and Cdc42, which peaked at 5 min. Taken together, Rac and Cdc42 are required for JNK activation by the -opioid receptor.

View larger version (34K): [in this window] [in a new window]   Fig. 6. Involvement of Rac and Cdc42 in -opioid receptor-induced activation of JNK. A, COS-7 cells were cotransfected with the plasmids encoding -opioid receptor and JNK-HA, together with dominant-negative RasS17N, RacT17N, N17Cdc42, or N17Rho (0.5 µg each). Transfectants were stimulated with 100 nM U-50,488H for 15 min. Values shown represent the mean ± S.E. from six independent experiments. *, U-50,488H significantly stimulated JNK activity (Bonferroni corrected t test, P < 0.05). B, THP-1 cells were stimulated by 100 nM U-50,488H for the indicated time, and activation of Cdc42 and Rac was measured by GST-PAK-PBD pull-down assay and Western blotting as described in Materials and Methods. Total cell lysates were immunoblotted with Rac and Cdc42 antibodies to confirm protein expressions. Results are representative of three separate experiments.

Stimulation of small GTPases requires the replacement of GDP with GTP, a process promoted by GEFs, and so we next explored the identity of the GEFs involved in signaling from -opioid receptor toward JNK. Ubiquitously expressed Sos belongs to the Dbl family of GEFs and possesses catalytic activity on Ras and Rac. Overexpression of its Dbl homology (DH) domain in COS-1 cells can trigger a Rac-dependent JNK activation (Nimnual et al., 1998). Additionally, the µ-opioid receptor requires Sos to mediate ERK activation (Hawes et al., 1998). We therefore investigated the contribution of Sos to the -opioid receptor-stimulated JNK activity. As the activity of endogenous Sos could be inhibited in the presence of its proline-rich motif (Sos-Pro; Hawes et al., 1998), the cDNAs encoding Sos-Pro was utilized here. As illustrated in Fig. 7, the interfering mutant Sos-Pro markedly reduced the JNK activity in transfected COS-7 cells following stimulation of the -opioid receptor. These findings support the idea that Sos is an important Rac-GEF for transmitting signals from the -opioid receptor to the JNK cascade.

View larger version (26K): [in this window] [in a new window]   Fig. 7. Expression of an interfering mutant of Sos abrogated JNK activation by -opioid receptor. COS-7 cells were cotransfected with the cDNAs of -opioid receptor and HA-JNK, together with either vector or Sos-Pro (0.5 µg for each). The transfected cells were exposed to 100 nM U-50,488H for 15 min. Results are the mean ± S.E. from four or five separate experiments. *, U-50,488H significantly induced JNK activation (Bonferroni corrected t test, P < 0.05).

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
Opioid receptors are detected in a variety of immunocytes including platelets, lymphocytes, macrophages, and monocytes (reviewed in McCarthy et al., 2001), implicating a pivotal role for opioids in the modulation of the immune system. Increasing evidence has suggested that opioid-elicited immunomodulations may occur through MAPK cascades. For instance, morphine-induced stimulations of JNK and p38 MAPK are accompanied by apoptosis of T cells and macrophages, respectively, in a caspase-dependent manner (Singhal et al., 2001, 2002). Herein, we showed that exposure of human monocytic THP-1 and transfected COS-7 cells to U-50,488H effectively stimulated JNK. The key signaling intermediates in the JNK pathway in response to stimulation by the -opioid receptors were also delineated (Fig. 8). This pathway required G subunits that are released upon G_i/o activation to stimulate JNK. Essential involvements of Src family tyrosine, FAK, Sos, Rac, and Cdc42 in the pathway were also demonstrated.

View larger version (31K): [in this window] [in a new window]   Fig. 8. A putative signaling pathway for -opioid receptor-induced JNK activation. Activated -opioid receptors initially trigger the release of G from PTX-sensitive Gi/Go, which is critical for activation of Src and autophosphorylation of FAK. By association between the SH2 domain of Src and the autophosphorylated Tyr397 of FAK, Src-FAK complex can be transiently formed and possibly is required for the JNK activation. Subsequently, the activities of Sos and/or other GEFs are increased, thus promoting the exchange of GDP for GTP on Rac and Cdc42 to invoke the JNK cascade.

Lai et al. (1995) overexpressed G_z in COS-7 cells transfected with the G_i-coupled -opioid receptors and observed a PTX-insensitive inhibition of adenylyl cyclase. Similar transfection studies revealed that upon coexpression with G₁₆, the -opioid receptor became capable of stimulating phospholipase C in the presence of PTX (Lee et al., 1998). These findings clearly indicate functional couplings of opioid receptors to G proteins (including G_z and G₁₆) other than G_i to regulate downstream signals. Therefore, it is reasonable expect that G₁₆ endogenously expressed in THP-1 cells could mediate -opioid receptor-activated JNK. However, our results did not support the participation of G₁₆ in the pathway since U-50,488H-stimuated JNK was completely suppressed by pretreating THP-1 cells with PTX (Fig. 2A). As G₁₆ and G_z are not found in COS-7 cells, the JNK activation was predictably abrogated by PTX (Fig. 2A). G_i signaling may also be predominant in other cellular responses such as -opioid receptor induced-lymphocyte chemotaxis (Arai et al., 1997). Upon stimulation of -opioid receptors, G instead of G_i appeared to be the primary signaling component because overexpression of G_t in COS-7 cells totally abolished the JNK activation (Fig. 2B and 8). These results were in agreement with an earlier report that COS-7 cells overexpressing G, but not constitutively activated G_i2, efficiently increased JNK activity (Coso et al., 1996). Additionally, G appears to be crucial for JNK activation by many G_i-coupled receptors, including m2 muscarinic (Coso et al., 1996) and -opioid (Kam et al., 2003) receptors. However, it should be noted that in certain cell types such as Rat-1 and human embryonal kidney 293 cells, a stimulatory effect of G_i on JNK has been demonstrated (Edamatsu et al., 1998; Yamauchi et al., 2000).

Src kinase, a downstream target of G, is generally believed to be a key component in GPCR-mediated MAPK signaling. PP1 or dominant-negative Src mutant can suppress G-dependent mitogen-activated protein kinase kinase 4 (Yamauchi et al., 1999) and JNK stimulation by endothelin (Yamauchi et al., 2002). Similarly, our results support the involvement of Src family tyrosine kinases in -opioid receptor-initiated JNK pathway. U-50,488H-induced Src phosphorylation at Y416 and JNK stimulation were abolished by PP1 or kinase-deficient Src (Figs. 3 and 8). To date, the precise mechanism by which GPCR stimulates Src activity has yet to be elucidated. In a reconstituted system, Src can be directly stimulated by activated G_i but not by G (Ma et al., 2000). However, Luttrell et al. (1996) found a potent stimulatory effect of G on Src activity in COS-7 cells, in which intracellular adaptor proteins might be involved. In -opioid-induced JNK activation, G is presumably more important than G_i because its removal by G_t effectively suppressed the activating signal. Apart from Src, phosphatidylinositol 3-kinase (PI3K) and the EGF receptor have been demonstrated to participate in GPCR-mediated stimulation of MAPK cascades (Lopez-Ilasaca et al., 1998; Belcheva et al., 2001). Nevertheless, pretreatment of THP-1 cells and transfected COS-7 cells with inhibitors for PI3K (wortmannin) or EGF receptor (AG1478) did not affect the -opioid receptor-induced JNK responses (Fig. 4; Kam et al., 2004), so their requirements in this signaling pathway were excluded.

The involvement of FAK in -opioid receptor signaling to JNK was also implicated by cotransfecting its site-directed mutants into COS-7 cells. We found that only the Tyr397 on FAK was essential for the JNK activation (Fig. 5A). Moreover, in response to U-50,488H, FAK was autophosphorylated on Tyr397 site, and it also formed a complex with Src (Fig. 5, B and C). These observations favor an alternative mechanism for enzymatic activation of Src, in which intramolecular interaction between its SH2 domain and a negative-regulatory Y527 residue is disrupted upon its association with Tyr397-phosphorylated FAK. Therefore, -opioid receptor-induced FAK phosphorylation on Tyr397 not only facilitated the formation of a complex between FAK and Src, but also increased Src activity, which in turn stimulated the JNK cascade (Fig. 8). The exact mechanism of -opioid receptor-induced FAK phoshosphorylation remains unclear. Nevertheless, we found an increased autophosphorylation of FAK in COS-7 cells overexpressing G₁₂, but not activated G_i2 mutant (G_i2QL; Fig. 5C). Moreover, PP2 failed to inhibit FAK autophosphorylation in Swiss 3T3 cells treated with several GPCR agonists including vasopressin, bradykinin, endothelin, and LPA (Salazar and Rozengurt, 2001). The -opioid receptor presumably requires G, but not Src family tyrosine kinases to induce FAK autophosphorylation. K454 is conserved at catalytic subdomain II of all eukaryotic protein kinase and is responsible for ATP-binding and regulation of catalytic activity. Instead, K454 on FAK was not necessary for -opioid receptor-stimulated JNK pathway due to the failure of FAKK454R to inhibit the JNK activation (Fig. 5A). The inhibitory effect of FAKK454R was possibly compensated by another site located in the kinase catalytic domain of FAK such as Y576 and Y577. Indeed, the formation of FAK-Src complex permits Src to further phosphorylate both Y576 and Y577, resulting in the promotion of the maximal FAK catalytic activity (reviewed in Schlaepfer et al., 1999). Similar to K454R mutant, FAKY925F was without effect on the JNK activation by U-50,488H (Fig. 5A), implicating that the interaction of FAK with Grb2 was not required for the pathway. But it does not mean that Grb2 is not important for -opioid receptors to stimulate JNK due to the presence of an alternative mechanism for recruitment of Grb2, such as Src/Shc/Grb2 pathway. Additional studies are required to determine the functional significance of these tyrosine residues in mediating GPCR-induced JNK activation.

It was not surprising that the -opioid receptor-initiated JNK pathway was primarily regulated by small GTPases Rac and Cdc42, but not Ras and Rho (Fig. 6 and 8), because constitutively activated Rac and Cdc42 have higher potency to stimulate JNK than the active mutants of Ras and Rho (reviewed in Davis, 2000). It has previously been shown that dominant-negative Rac and Cdc42 can abolish Src-dependent JNK activation, whereas dominant-negative Ras is ineffective (Li and Smithgall; 1998). In the present study, we show that at least one GEF, Sos, appears to provide the linkage from the -opioid receptor to Rac. Recently, Innocenti et al. (2002) illustrated the importance of adaptor proteins on the GEF activity of Sos; Sos exclusively displays Rac-GEF activity upon formation of a tricomplex by association with Eps8 (a SH3 domain-containing adaptor protein) and E3b1 (a scaffold protein). Since complete suppression of the -opioid receptor-stimulated JNK was observed in the presence of Sos-Pro (Fig. 7), Sos-Pro can probably down-regulate the Cdc42 signal as well. Since the proline-rich domains of Sos and Vav (a Rho family GEF) can associate with the SH3 domain of Grb2 (reviewed in Whitehead et al., 1997), Sos-Pro may also bind to the upstream adaptor of the Cdc42 GEF. On the other hand, the DH domain of Sos contributes to Rac-dependent JNK stimulation (Nimnual et al., 1998) but is down-regulated by its adjacent PH domain via their intramolecular interaction (Nimnual et al., 1998). Inhibition on the DH domain can be relieved by the binding of PI3K products (PI-3,4,5-P3 and PI-3,4-P3; Nimnual et al., 1998) to the PH domain, suggesting that PI3K can regulate Sos activity. However, -opioid receptor did not require PI3K to stimulate JNK (Kam et al., 2004), and so the receptors presumably use a mechanism independent of the PI3K pathway to regulate Sos. In this regard, an association of G₁₂ with the PH-Sos (Sawai et al., 1999) is a possible means for regulating Sos.

In conclusion, we have demonstrated that JNK activation could be induced in monocytic THP-1 cells and transfected COS-7 cells following stimulation of -opioid receptors. The putative signaling pathway was also defined, in which -opioid receptors utilized G released from PTX-sensitive G_i/G_o to invoke JNK cascade. Additionally, the pathway appeared to be mediated by several signaling intermediates including Src, FAK, Sos, Rac, and Cdc42. The contribution of opioids in the regulation of inflammatory responses, ranging from chemotaxis to cytokine production, has already been established (reviewed in McCarthy et al., 2001). Given that migration of immunocytes necessitates rearrangement of actin cytoskeleton, which may be correlated with the Rac/Cdc42-dependent JNK pathway, it remains to be determined whether the demonstrated ability of -opioid receptors to stimulate JNK in THP-1 cells is important for monocytic chemotaxis.

	Acknowledgements

 
We are extremely grateful to the following individuals for kindly providing the various cDNAs: T. A. Voyno-Yasenetskaya, G. M. Bokoch, R. J. Lefkowitz, T. Hunter, and M. Symons. We thank Dr. David New for helpful discussions.

	Footnotes

 
This work was supported in part by grants from the University Grants Committee of Hong Kong (AoE/B-15/01), the Research Grants Council of Hong Kong (HKUST 6115/00M and 2/99C), and the Hong Kong Jockey Club. Y.H.W. was a recipient of the Croucher Senior Research Fellowship.

DOI: 10.1124/jpet.104.065078.

ABBREVIATIONS: IL, interleukin; U50,488H, (±)-trans-U-50,488 methanesulfonate; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated protein kinase; JNK, c-Jun N-terminal kinase; GPCR, G protein-coupled receptor; EGF, epidermal growth factor; FAK, focal adhesion kinase; GEF, guanine nucleotide exchange factors; Sos, Son-of-sevenless; HA, hemagglutinin; PBD, p21-binding domain; PTX, pertussis toxin; AG1478, N-(3-chlorophenyl)-6,7-dimethoxy-4-quinazolinanine; nor-BNI, nor-binaltorphimine; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; LPA, lysophosphatidic acid; SH, Src homology; DH, Dbl homology; PI3K, phosphatidylinositol 3-kinase.

Address correspondence to: Prof. Yung H. Wong, Department of Biochemistry, the Molecular Neuroscience Center, and the Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong. E-mail: boyung{at}ust.hk

	References

Top Abstract Materials and Methods Results Discussion References

 

Arai H, Tsou CL, and Charo IF (1997) Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by dimers released by activation of G_i-coupled receptors. Proc Natl Acad Sci USA 94: 14495-14499.[Abstract/Free Full Text]

Behrens A, Sabapathy K, Graef I, Cleary M, Crabtree GR, and Wagner EF (2001) Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc Natl Acad Sci USA 98: 1769-1774.[Abstract/Free Full Text]

Belcheva MM, Szúcs M, Wang D, Sadee W, and Coscia CJ (2001) µ-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal factor receptor transactivation. J Biol Chem 276: 33847-33853.[Abstract/Free Full Text]

Belcheva MM, Vogel Z, Ignatova E, Avidor-Reiss T, Zippel R, Levy R, Young EC, Barg J, and Coscia CJ (1998) Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves G subunits. J Neurochem 70: 635-645.[Medline]

Belkowski SM, Alicea C, Eisenstein TK, Adler MW, and Rogers TJ (1995) Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J Pharmacol Exp Ther 273: 1491-1496.[Abstract/Free Full Text]

Bohn LM, Belcheva MM, and Coscia CJ (2000) Mitogenic signaling via endogenous -opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade. J Neurochem 74: 564-573.[CrossRef][Medline]

Coso OA, Teramoto H, Simonds WF, and Gutkind JS (1996) Signaling from G protein-coupled receptors to c-Jun kinase involves subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway. J Biol Chem 271: 3963-3966.[Abstract/Free Full Text]

Daub H, Weiss FU, Wallasch C, and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature (Lond) 379: 557-560.[CrossRef][Medline]

Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252.[CrossRef][Medline]

Dong C, Yang D, Tournier C, Whitmarsh A, Xu J, Davis R, and Flavell R (2000) JNK is required for effector T-cell function but not for T-cell activation. Nature (Lond) 405: 91-94.[CrossRef][Medline]

Edamatsu H, Kaziro Y, and Itoh H (1998) Expression of an oncogenic mutant G_i2 activates Ras in Rat-1 fibroblast cells. FEBS Lett 440: 231-234.[CrossRef][Medline]

Gavériaux C, Peluso J, Simonin F, Laforet J, and Kieffer B (1995) Identification of - and -opioid receptor transcripts in immune cells. FEBS Lett 369: 272-276.[CrossRef][Medline]

Hawes BE, Fried S, Yao X, Weig B, and Graziano MP (1998) Nociceptin (ORL-1) and µ-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a G_i-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization. J Neurochem 71: 1024-1033.[Medline]

Igishi T, Fukuhara S, Patel V, Katz BZ, Yamada KM, and Gutkind JS (1999) Divergent signaling pathways link focal adhesion kinase to mitogen-activated protein kinase cascades. Evidence for a role of paxillin in c-Jun NH₂-terminal kinase activation. J Biol Chem 274: 30738-30746.[Abstract/Free Full Text]

Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP, and Scita G (2002) Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol 156: 125-136.[Abstract/Free Full Text]

Kam AY, Chan AS, and Wong YH (2003) Rac and Cdc42-dependent regulation of c-Jun N-terminal kinases by the -opioid receptor. J Neurochem 84: 503-513.[CrossRef][Medline]

Kam AY, Chan AS, and Wong YH (2004) Phosphatidylinositol-3 kinase is distinctively required for µ- but not -opioid receptor-induced activation of c-Jun N-terminal kinase. J Neurochem, in press.

Lai HW, Minami M, Satoh M, and Wong YH (1995) G_z coupling to the rat -opioid receptor. FEBS Lett 360: 97-99.[CrossRef][Medline]

Lawrence DM and Bidlack JM (1992) Kappa opioid binding sites on the R1.1 murine lymphoma cell line: sensitivity to cations and guanine nucleotides. J Neuroimmunol 41: 223-230.[CrossRef][Medline]

Lee JW, Joshi S, Chan JS, and Wong YH (1998) Differential coupling of µ-, - and -opioid receptors to G₁₆-mediated stimulation of phospholipase C. J Neurochem 70: 2203-2211.[Medline]

Li J and Smithgall TE (1998) Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation. J Biol Chem 273: 13828-13834.[Abstract/Free Full Text]

Lopez-Ilasaca M, Gutkind JS, and Wetzker R (1998) Phosphoinositide 3-kinase is a mediator of G-dependent Jun kinase activation. J Biol Chem 273: 2505-2508.[Abstract/Free Full Text]

Luttrell LM, Hawes BE, van Biesen T, Luttrell DK, Lansing T, and Lefkowitz RJ (1996) Role of c-Src tyrosine kinase in G protein-coupled receptor- and G subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 271: 19443-19450.[Abstract/Free Full Text]

Ma YC, Huang J, Ali S, Lowery W, and Huang XY (2000) Src tyrosine kinase is a novel direct effector of G proteins. Cell 102: 635-646.[CrossRef][Medline]

McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, and Rogers TJ (2001) Opioids, opioid receptors and the immune response. Drug Alcohol Depend 62: 111-123.[CrossRef][Medline]

Ni X, Lin BC, Song CY, and Wang CH (1999) Dynorphin A enhances mitogen-induced proliferative response and interleukin-2 production of rat splenocytes. Neuropeptides 33: 137-143.[CrossRef][Medline]

Nimnual AS, Yatsula BA, and Bar-Sagi D (1998) Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science (Wash DC) 279:.

Sabapathy K, Kallunki T, David JP, Graef I, Karin M, and Wagner EF (2001) c-Jun NH₂-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med 193: 317-328.[Abstract/Free Full Text]

Sawai T, Hirakawa T, Yamada K, and Nishizawa Y (1999) Interaction between pleckstrin homology domains and G protein -subunits: analyses of kinetic parameters by a biosensor-based method. Biol Pharm Bull 22: 229-233.[Medline]

Salazar EP and Rozengurt E (2001) Src family kinase are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J Biol Chem 276: 17788-17795.[Abstract/Free Full Text]

Schlaepfer DD, Hauck CR, and Sieg DJ (1999) Signaling focal adhesion kinase. Prog Biophys Mol Biol 71: 435-478.[CrossRef][Medline]

Schlaepfer DD and Hunter T (1997) Focal adhesion kinase overexpression enhances Ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem 272: 13189-13195.[Abstract/Free Full Text]

Shapira M, Vogel Z, and Sarne Y (2000) Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell Mol Neurobiol 20: 291-304.[CrossRef][Medline]

Singhal PC, Bhaskaran M, Patel J, Patel K, Kasinath BS, Duraisamy S, Franki N, Reddy K, and Kapasi AA (2002) Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol 168: 4025-4033.[Abstract/Free Full Text]

Singhal PC, Kapasi A, Reddy K, and Franki N (2001) Opiates promote T cell apoptosis through JNK and caspase pathway. Adv Exp Med Biol 493: 127-135.[Medline]

Whitehead IP, Campbell S, Rossman KL, and Der CJ (1997) Dbl family proteins. Biochim Biophys Acta 1332: F1-F23.[Medline]

Yamauchi J, Kawano T, Nagao M, Kaziro Y, and Itoh H (2000) G_i-dependent activation of c-Jun N-terminal kinase in human embryonal kidney 293 cells. J Biol Chem 275: 7633-7640.[Abstract/Free Full Text]

Yamauchi J, Kaziro Y, and Itoh H (1999) Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein subunit in human embryonal kidney 293 cells. J Biol Chem 274: 1957-1965.[Abstract/Free Full Text]

Yamauchi J, Miyamoto Y, Kokubu H, Nishii H, Okamoto M, Sugawara Y, Hirasawa A, Tsujimoto G, and Itoh H (2002) Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1 and Cdc42. FEBS Lett 527: 284-288.[CrossRef][Medline]

Zhang L and Rogers TJ (2000) -opioid regulation of thymocyte IL-7 receptor and C-C chemokine receptor 2 expression. J Immunol 164: 5088-5093.[Abstract/Free Full Text]

This article has been cited by other articles:

				M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria J. Neurosci., October 24, 2007; 27(43): 11614 - 11623. [Abstract] [Full Text] [PDF]

M. R. Bruchas, T. Yang, S. Schreiber, M. DeFino, S. C. Kwan, S. Li, and C. Chavkin Long-Acting {kappa} Opioid Antagonists Disrupt Receptor Signaling And P